Park, I. H., Im, S., Jung, K. H., Sohn, J. H., Park, Y. H., Lee, K. S., . . . Ro, J. (2019). Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01). Cancer Res Treat.
Chicago Stili AlıntıPark, In Hae, et al. "Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine Versus Capecitabine Monotherapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)." Cancer Res Treat 2019.
MLA AlıntıPark, In Hae, et al. "Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine Versus Capecitabine Monotherapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)." Cancer Res Treat 2019.